These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33487580)

  • 1. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population.
    Milito P; Sorrentino L; Pietrantonio F; Di Russo A; Citterio D; Mazzaferro V; Cosimelli M
    Dig Liver Dis; 2021 Aug; 53(8):1041-1047. PubMed ID: 33487580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
    Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
    Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical staging accuracy and the use of neoadjuvant chemoradiotherapy for cT3N0 rectal cancer: Propensity score matched National Cancer Database analysis.
    Burneikis D; Lavryk O; Gorgun E; Liska D; Valente M; Sklow B; Kalady M; Steele SR
    Am J Surg; 2021 Mar; 221(3):561-565. PubMed ID: 33223074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
    Ye W; Shi L; Qian L; Sun Y; Sun X
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results.
    Merkel S; Weber K; Göhl J; Agaimy A; Fietkau R; Hohenberger W; Grützmann R; Hermanek P
    Int J Colorectal Dis; 2017 Sep; 32(9):1295-1301. PubMed ID: 28730369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.
    Bergquist JR; Thiels CA; Shubert CR; Habermann EB; Hayman AV; Zielinski MD; Mathis KL
    World J Surg; 2016 Feb; 40(2):447-55. PubMed ID: 26566779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
    Zhou P; Goffredo P; Ginader T; Thompson D; Hrabe J; Gribovskaja-Rupp I; Kapadia M; Hassan I
    J Surg Oncol; 2021 Jan; 123(1):278-285. PubMed ID: 33022750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
    Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
    J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer.
    Venigalla S; Chowdhry AK; Wojcieszynski AP; Lukens JN; Plastaras JP; Metz JM; Ben-Josef E; Mahmoud NN; Reiss KA; Shabason JE
    Clin Colorectal Cancer; 2018 Sep; 17(3):e557-e568. PubMed ID: 29910004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.
    Yang H; Yao Z; Cui M; Xing J; Zhang C; Zhang N; Liu M; Xu K; Tan F; Su X
    BMC Cancer; 2020 Aug; 20(1):761. PubMed ID: 32795280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis.
    Spiegel DY; Boyer MJ; Hong JC; Williams CD; Kelley MJ; Salama JK; Palta M
    J Natl Compr Canc Netw; 2020 Jan; 18(1):52-58. PubMed ID: 31910388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis.
    Lin S; Lai H; Qin Y; Chen J; Lin Y
    Int J Clin Exp Pathol; 2015; 8(9):10680-8. PubMed ID: 26617778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.